PharmaLundensis
0,10 SEK
+27,46 %
Mindre end 1K følgere
PHAL
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorkonsensus
+27,46 %
-58,27 %
-60,19 %
-57,93 %
-79,13 %
-81,91 %
-81,90 %
-87,40 %
-96,84 %
PharmaLundensis is a research company. The company's main focus is on the treatment of serious lung diseases. Diseases that the company specializes in include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and influenza-induced pulmonary failure. In addition to its main business, technical systems for handling drug emissions are developed. PharmaLundensis has its headquarters in Lund.
Læs mereMarkedsværdi
6,65 mio. SEK
Aktieomsætning
13,74 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin
Omsætning
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
21.5
2026
Delårsrapport Q1'26
20.8
2026
Delårsrapport Q2'26
19.11
2026
Delårsrapport Q3'26